Spero Therapeutics secures $105M royalty-backed financing deal
Go back to Spero Therapeutics secures $105M royalty-backed financing deal| KKR & CO. L.P. (NYSE: KKR) | Delayed: 95.53 -1.58 (1.63%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $97.11 | 52 Week High | $17.84 | |||
| Open | $96.34 | 52 Week Low | $10.89 | |||
| Day High | $97.47 | P/E | 41.53 | |||
| Day Low | $94.83 | EPS | $2.30 | |||
| Volume | 2,564,619 | |||||
| SmartPros Ltd. (NASDAQ: SPRO) | Delayed: 1.27 -0.11 (7.97%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1.38 | 52 Week High | $3.85 | |||
| Open | $1.38 | 52 Week Low | $1.25 | |||
| Day High | $1.41 | P/E | N/A | |||
| Day Low | $1.25 | EPS | $-0.28 | |||
| Volume | 1,990,403 | |||||

